Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

Arbutus Biopharma Corporation

NASDAQ: ABUSHealthcare / Biotechnology / Canada
4.60+0.16+3.60%Vol 159 3311Y Perf -2.74%
Dec 12th, 2018 16:00
BID4.59 ASK4.60
Open4.48 Previous Close4.44
Pre-Market- After-Trading4.60
 - -%  - -%
Target Price
5.25 
Analyst Rating
Moderate Buy 1.67
Potencial %
14.13 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-100/-100 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-100/-100 
Growth Ranking
★★+     47.78
Insiders Shares Cnt. % 3/6/12M
-/-100/-100 
Income Ranking
 —    -
Market Cap (mil)255 
Earnings Rating
Strong Buy
Price Range Ratio 52wk %
6.87 
Earnings Date
7th Nov 2018

Today's Price Range

4.404.62

 

52wk Range

4.0112.60

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Month
0.23%
3 Months
-53.51%
6 Months
-26.00%
1 Year
-2.74%
3 Years
-2.42%
5 Years
-40.00%

Quotes

Name / TickerPriceChg.Chg.%
ABUS4.600.16003.60
AAPL169.100.47000.28
GOOG1 063.6811.93001.13
MSFT109.080.49000.45
XOM76.02-0.6600-0.86
WFC47.74-0.0200-0.04
JNJ147.100.60000.41
FB144.502.42001.70
GE6.71-0.0500-0.74
JPM101.020.65000.65
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
11.30
Current Ratio
11.40
Long Term Debt to Total Capital
0.06
Total Debt to Equity
0.09
Interest Coverage
-576.30
Leverage Ratio 2.30
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
-851.20
EBIT Margin
-1 516.90
EBITDA Margin
-1 483.10
Pre-tax Profit Margin
-6 902.50
Profit Margin
-
ValuationValueIndustryS&P 500US Markets
PE Ratio
-
PB Ratio
2.66
PS Ratios
-75.32
Price to Cash Flow
7 665.10
Price to Free Cash Flow
-3.90
Cash Flow Per Share
-1.11
Price to Tangible Book
9.58
Book Value per Share
1.65
Enterprise Value (in ths.)
232 892
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
-59.26
ROE last 12 Months
-64.12
Return on Assets (5Y Avg)
-48.10
ROA last 12 Months
-34.25
Return on Capital (5Y Avg)
-50.09
ROC last 12 Months
-65.57
Return on invested Capital Q
-26.41
Return on invested Capital Y
-47.99
Assets Turnover
0.00
Receivables Turnover
-0.50
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
-3 241
Revenue per Share
-0.06
Revenue Growth 3 Years
-32.08
Revenue Growth 5 Years
-18.87
DividendsValueIndustryS&P 500US Markets
Dividend Yield
-
Dividend Rate
-
Dividend Growth 3 Years
-
Dividend Growth 5 Years
-

Earnings HistoryEstimateReportedSurprise %
Q03 2018-0.39-0.3023.08
Q02 2018-0.35-0.44-25.71
Q01 2018-0.38-0.365.26
Q04 2017-0.39-0.90-130.77
Q03 2017-0.38-0.1755.26
Q02 2017-0.35-0.2820.00
Q01 2017-0.30-0.34-13.33
Q04 2016-0.38-0.380.00
Earnings Per EndEstimateRevision %Trend
12/2018 QR-0.3915.22Positive
12/2018 FY-1.498.02Positive
3/2019 QR-0.42-13.51Negative
12/2019 FY-1.69-6.29Negative
Next Report Date-
Estimated EPS Next Report-0.39
Estimates Count3
EPS Growth Next 5 Years %-
Volume Overview
Volume159 331
Shares Outstanding (in ths.)55 480
Trades Count843
Dollar Volume605 052
Avg. Volume327 913
Avg. Weekly Volume142 196
Avg. Monthly Volume185 414
Avg. Quarterly Volume391 150

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

35%65%

Bearish Bullish

58%42%

Bearish Bullish

49%51%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (66.67 %)
3 (75.00 %)
2 (50.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (33.33 %)
1 (25.00 %)
2 (50.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingModerate Buy
1.67
Strong Buy
1.50
Moderate Buy
2.00

There are no comments yet.

News